“Our strategy is to continue our long track record of growth by being the ‘go to’ European specialist pharma company partner of choice. We acquire, develop and commercialise specialist and transformative products through our infrastructure  that add value to healthcare systems and make a difference to patients. “

Peter Stein
CEO, Norgine